Skip to content
2000
Volume 14, Issue 33
  • ISSN: 1381-6128
  • E-ISSN: 1873-4286

Abstract

Anxiety disorders are highly prevalent and disabling disorders, which are commonly treated using pharmacotherapeutic and psychotherapeutic approaches. Benzodiazepines are widely used in the treatment of acute anxiety states whereas both serotonergic acting antidepressants and gamma-aminobutyric acid (GABA) ergic substances represent standard treatments on the long term. Due to the dependence potential of the first mentioned pharmacological group and the slow onset of action and the specific side effect profile of the latter groups, there is need for new pharmacologic anxiolytic treatment strategies. In this issue of CPD, new insights in pathophysiological mechanisms of anxiety disorders together with information about actual available and novel anxiolytic acting drugs are provided.

Loading

Article metrics loading...

/content/journals/cpd/10.2174/138161208786848847
2008-11-01
2025-06-16
Loading full text...

Full text loading...

/content/journals/cpd/10.2174/138161208786848847
Loading

  • Article Type:
    Research Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test